Book Review: GABA and Glutamate in the Human Brain

  title={Book Review: GABA and Glutamate in the Human Brain},
  author={Ognen A. C. Petroff},
  journal={The Neuroscientist},
  pages={562 - 573}
  • O. Petroff
  • Published 1 December 2002
  • Biology
  • The Neuroscientist
Cortical excitability reflects a balance between excitation and inhibition. Glutamate is the main excitatory and GABA the main inhibitory neurotransmitter in the mammalian cortex. Changes in glutamate and GABA metabolism may play important roles in the control of cortical excitability. Glutamate is the metabolic precursor of GABA, which can be recycled through the tricarboxylic acid cycle to synthesize glutamate. GABA synthesis is unique among neurotransmitters, having two separate isoforms of… 

Figures and Tables from this paper

Introductory Chapter: GABA/Glutamate Balance: A Key for Normal Brain Functioning
The basis of information transfer in the mammalian central nervous system (CNS) consists of excitation and inhibition of neuronal networks, and coordination between these two principal neurotransmitters ensures adequate rhythmic activity.
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression
The astroglial distribution of the two glutamate transporters and l-glutamate-ammonia ligase strongly links glia to the pathophysiology of depression and challenges the conventional notion that depression is solely a neuronal disorder.
Oligodendroglial GABAergic Signaling: More Than Inhibition!
This review elaborate on the physiological role of GABA receptors within the oligodendrocyte lineage and conclude with a description of these receptors as putative targets in treatments of CNS diseases.
Effects of the glutamic acid decarboxylase (GAD) inhibitor semicarbazide and anti-GAD autoantibodies-containing immunoglobulin G on neuronal network activity within the motor cortex
The results of this study show that IgG of SPS patients is indeed capable of altering GABAergic synaptic transmission, thus further supporting the hypothesis of an autoimmune origin of the stiff-person syndrome.
Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis
These findings indicate that GABA co-release is a general feature of midbrain dopaminergic neurons that relies on GABA uptake from the extracellular milieu as opposed to de novo synthesis.
Glutamate and glutamine: a review of in vivo MRS in the human brain
This work has shown that Glu/Gln quantitation in the human brain in an array of conditions (e.g. mental illness, tumor, neuro‐degeneration) as well as in normal brain function is stable.
Engineering a GABA endowed with pharmacological CNS activity when given by an extracerebral route
It is shown herein that extracerebral administration may be, however, pharmacologically effective in controlling experimental convulsive attacks when GABA is submitted to sublimation under vacuum just before use.


Neuroactive Amino Acids in Focally Epileptic Human Brain: A Review
Nuclear magnetic resonance spectroscopy reveals that patients with poorly controlled complex partial seizures have a significant diminution in occipital lobe gamma aminobutyric acid (GABA) concentration, and NMRS studies show that vigabatrin, a GABA-T inhibitor and effective antiepileptic, significantly increases brain GABA.
Epilepsy and gamma-aminobutyric acid-mediated inhibition.
GABA metabolism in the substantia nigra, cortex, and hippocampus during status epilepticus
The data suggest that the observed reduction of the rate of GABA synthesis in substantia nigra could play a key role in seizure spread in this model of status epilepticus.
Alterations of GABA-mediated synaptic transmission in human epilepsy.
It is estimated that 60 to 70% of the present patient population had deficient GABAergic transmission in epileptic foci as compared to nonepileptic brain tissue from the same patients, suggesting that other neurotransmitter and neurohumoral systems certainly play a role in the epileptic process.
Hippocampal GABA transporter function in temporal-lobe epilepsy
In amygdala-kindled rats, a model for human epilepsy, a decrease in glutamate-induced GABA release was associated with a 48% decrease in the number of GABA transporters, and this data suggest that temporal-lobe epilepsy is characterized in part by a loss of glutamate-stimulated GABA release that is secondary to a reduction in theNumber of GABAtransporters.
On the role of GABA in vertebrate polyamine metabolism.
  • N. Seiler
  • Biology, Chemistry
    Physiological chemistry and physics
  • 1980
4-Aminobutyric acid (GABA), the major inhibitory neurotransmitter in vertebrate brain, is formed not only by decarboxylation of glutamic acid but also directly from putrescine. Two pathways can be
Regulation of gamma-aminobutyric acid synthesis in the brain.
Brain contains at least two molecular forms of glutamate decarboxylase (GAD), the principal synthetic enzyme for GABA, and at least 50% of GAD is present in brain as apoenzyme, which serves as a reservoir of inactive GAD that can be drawn on when additional GABA synthesis is needed.
Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
With vigabatrin, elevated CSF and brain GABA was associated with improved seizure control and increased GABA concentrations appear to reduce GABA synthesis in humans as it does in animals.